Abstract:
:Gastric cancer is a common malignancy worldwide. However, the molecular mechanisms underlying this malignancy remain unclear and there are a lack of effective drugs. The present study aimed to investigate the antitumor effect of Dihydroartemisinin (DHA) or inhibition of Tankyrases (TNKS), and determine the underlying molecular mechanisms of gastric cancer. Immunohistochemistry and immunofluorescence analyses were performed to detect the expression levels of TNKS, epithelial-to-mesenchymal transition (EMT) and Wnt/β-catenin pathway-related proteins in gastric cancer tissues and adjacent normal tissues. The Cell Counting Kit-8 assay was performed to assess the viability of HGC-27 and AGS cells following treatment with different concentrations of HLY78 (a Wnt activator) or DHA. Following treatment with HLY78, DHA or small interfering (si)-TNKS1/si-TNKS2, colony formation and migratory abilities were assessed via the colony formation, wound healing and Transwell assays. Furthermore, western blot and immunofluorescence analyses were performed to detect the expression levels of TNKS, EMT- and Wnt/β-catenin-related proteins. The results demonstrated that the expression levels of TNKS, AXI2, β-catenin, N-cadherin and Vimentin were upregulated, whereas E-cadherin expression was downregulated in gastric cancer tissues compared with normal tissues. Furthermore, HLY78 and DHA suppressed the viability of HGC-27 and AGS cells, in a concentration-independent manner. Notably, TNKS knockdown or treatment with DHA suppressed colony formation, migration, TNKS expression, EMT and the Wnt/β-catenin pathway. Opposing effects were observed following treatment with HLY78, which were ameliorated following co-treatment with DHA. Taken together, these results suggest that DHA or inhibition of TNKS can suppress the proliferation and migration of gastric cancer cells, which is partly associated with inactivation of the Wnt/β-catenin pathway and EMT process.
journal_name
Oncol Lettjournal_title
Oncology lettersauthors
Ma Y,Zhang P,Zhang Q,Wang X,Miao Q,Lyu X,Cui B,Ma Hdoi
10.3892/ol.2021.12949keywords:
["DHA","EMT","TNKS","Wnt\/β-catenin","gastric cancer","migration"]subject
Has Abstractpub_date
2021-10-01 00:00:00pages
688issue
4eissn
1792-1074issn
1792-1082pii
OL-0-0-12949journal_volume
22pub_type
杂志文章相关文献
Oncology Letters文献大全abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.441
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.417
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.450
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.459
更新日期:2012-01-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.503
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.489
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.481
更新日期:2012-02-01 00:00:00
abstract::Individual therapy based on various pathohistological types and biological characteristics may be the practical trend of advanced non-small cell lung cancer (NSCLC) treatment. To provide a molecular criterion for drug selection, we investigated the incidence of somatic mutation and mRNA expression levels of common gen...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.502
更新日期:2012-02-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.485
更新日期:2012-02-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.519
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.544
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.526
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2011.512
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.550
更新日期:2012-03-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.577
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.564
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.580
更新日期:2012-04-01 00:00:00
abstract::Inference of accurate gene annotations requires integration of existing biological knowledge, structured in a form of ontology, with data from transcriptomics high-throughput technologies. This undertaking requires developing algorithms that integrate genome-scale data, even for model organisms. Gene relevance network...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.584
更新日期:2012-04-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.628
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.619
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.596
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.614
更新日期:2012-05-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.654
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.639
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.647
更新日期:2012-06-01 00:00:00
abstract::Noonan syndrome (NS) is a genetic disorder characterised by short stature, facial dysmorphia, congenital heart defects and mildly lowered intellectual abilities. Research has mainly focused on genetic and somatic aspects, while intellectual and cognitive functioning has been documented scarcely. Also, to date studies ...
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.643
更新日期:2012-06-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.693
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.706
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.671
更新日期:2012-07-01 00:00:00
abstract::Ascites can be found in a variety of diseases and may represent either a late complication or the clinical sign of a pathologic condition. The presence of even small fluid collections in peritoneal recess can be easily detected by CT. A number of reports confirm CT prediction of the benign/malignant nature of ascites....
journal_title:Oncology letters
pub_type: 杂志文章
doi:10.3892/ol.2012.700
更新日期:2012-07-01 00:00:00